Accurate Classification System for Patients With COVID-19 Pneumonitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

669 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-12-10

Study Completion Date

2020-03-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Novel Nomogram to Predict Severity of COVID-19

NCT04366024

COVID-19 Disease Nomogram Model

COMPLETED

Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment

NCT06028217

Hospital-acquired Pneumonia Antibiotic Resistant Infection

NOT_YET_RECRUITING

A New Screening Strategy for 2019 Novel Coronavirus Infection

NCT04281693

Novel Coronavirus Infection Pneumonia

UNKNOWN NA

Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital

NCT04481360

Coronavirus

UNKNOWN

Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia

NCT04522076

COVID 19

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group.
2. Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility.
3. Compared with SEPSIS and CURB-65 grading system with the grading system we established.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

modeling cohort

The 445 patients were grouped in chronological order.

Intervention Type OTHER

validating colort

The remaining 224 patients.

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.

Exclusion Criteria

* Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia.
* Suspected patient review refers to the negative nucleic acid test.

Eligible Sex

ALL

Accepts Healthy Volunteers

No